N E W S
38 Million American Adults are Binge Drinkers, CDC Says
The
Centers for Disease Control and Prevention (CDC) say 38
million American adults are binge drinkers, and most of
them are ages 18 to 34. In a new report, the CDC says that
while binge drinking is more common among young adults,
those age 65 and older who binge drink do so more often
— an average of five to six times a month.
Binge
drinking is defined as men who have five or more drinks in
one sitting, and women who have four or more drinks at one
time, HealthDay reports.
Binge
drinking is responsible for more than half of the 80,000
alcohol-related deaths each year in the United States, and
accounts for about three-fourths of the more than $200
billion in costs from alcohol abuse, according to the CDC.
“Binge
drinking causes a wide range of health, social and
economic problems and this report confirms the problem is
really widespread,” CDC Director Thomas R. Frieden,
M.D., M.P.H. said in a news release. “We need to work
together to implement proven measures to reduce binge
drinking at national, state and community levels.”
The
CDC found binge drinking is more common among people with
household incomes of $75,000 or more. However, binge
drinkers with household incomes of less than $25,000 have
the largest number of drinks per sitting—an average of
eight to nine drinks.
Researchers Seek to Predict Stress-Induced Substance Abuse Relapse
With
more than two thirds of people relapsing after starting
treatment for substance use disorders, researchers are
looking for ways to predict a person’s susceptibility to
return to drug or alcohol use. Researchers at the Yale
Stress Center in New Haven, CT, are developing biological
markers of recovery to predict who will relapse, and when.
Having
validated markers to measure a person’s risk of relapse
could help doctors better predict who is at highest risk
and tailor treatments for them, says Rajita Sinha, PhD,
Director of the Yale Stress Center. For instance, a doctor
might recommend an extended stay in residential treatment,
or more intense behavioral treatment for patients who are
likely to relapse.
While
much is known about the effects of stress on addiction,
much less is understood about how stress affects a
person’s risk of relapse and jeopardizes recovery,
according to Dr. Sinha. “When the regions of the brain
involved in regulating stress are not working well, it
increases a person’s vulnerability to relapse,” she
says. “We want to find those neural and biological
measures that predict whether this will occur.”
She
and her colleagues are testing a number of biological
measures of stress in people with various substance use
disorders, including cocaine addiction and alcoholism.
They are studying patients who are discharged from
inpatient substance abuse treatment, to see if and when
they relapse. The researchers are looking for links
between relapse and biological markers including high
levels of the chemical cortisol and high blood levels of a
protein called brain-derived neurotrophic factor (BDNF),
as well as brain atrophy in specific regions of the brain.
In
a recently published study in the Archives of General
Psychiatry, Dr. Sinha found several markers of increased
risk of alcohol relapse, including high morning levels of
the hormone corticotrophin. Another recent study,
published in Biological Psychiatry, found high levels of
BDNF in cocaine-dependent patients was predictive of an
early relapse.
Dr.
Sinha’s lab is also studying treatments to reduce
stress-induced substance abuse. One recent pilot study
found an older drug for hypertension called prazosin
appears to decrease stress-induced alcohol craving. “We
are also identifying newer drugs that could help those
most susceptible to stress,” she notes. “But first we
need to validate biological markers so we know who will
benefit from these treatments.”
Prescription Drug Abuse Results in One Death Every 19 Minutes in U.S.
One
person dies every 19 minutes from prescription drug abuse
in the United States, according to the Centers for Disease
Control and Prevention (CDC). An estimated 27,000
unintentional drug overdose deaths occurred in 2007, UPI
reports.
The
rise in unintentional drug overdose deaths has been driven
by an increase in use of opioids, the CDC notes in the
Morbidity and Mortality Weekly Report. For every
unintentional overdose death linked to opioids, nine
people are admitted for substance abuse treatment, 35
people go to the emergency room, 161 report drug abuse or
dependence, and 461 report non-medical uses of opioids.
The
rate of opioid misuse and overdose deaths are highest
among non-Hispanic whites, men ages 20-64, and poor and
rural populations.
The National Response to this Crisis
At
the national level, the White House Office of National
Drug Control Policy establishes policies, priorities, and
objectives for the nation’s drug control program to
reduce illicit drug use, manufacturing, and trafficking;
drug-related crime and violence; and drug-related health
consequences. In May 2010, President Obama released the
National Drug Control Strategy, which outlined the
Administration’s science-based public health approach to
drug policy. In 2011, the strategy was expanded to place
special focus on certain populations, such as service
members and their families, college students, women and
children, and persons in the criminal justice system.
When
developing a national approach to address prescription
drug overdose, any policy must balance the desire to
minimize abuse with the need to ensure legitimate access
to these medications, and its implementation must bring
together a variety of federal, state, local, and tribal
groups. The Administration’s plan for addressing
prescription drug abuse, Epidemic: Responding to
America’s Prescription Drug Abuse Crisis, which was
released in April 2011, includes four components:
education, tracking and monitoring, proper medication
disposal, and enforcement.
The
majority of health-care providers receive minimal
education regarding addiction and might be at risk for
prescribing an addictive medication without fully
appreciating the potential risks. Therefore, the first
component of the plan calls for mandatory prescriber
education. This would require prescribers to be trained on
appropriate prescribing of opioids before obtaining their
controlled substance registration from the Drug
Enforcement Administration (DEA). Parents and patients
also must be educated about the dangers and prevalence of
prescription drug abuse and how to use prescription drugs
safely. To achieve this, the plan calls for a
public/private partnership to develop an educational
campaign directed at parents and patients.
The
second component of the plan calls for prescription drug
monitoring programs to be operational in all states and
mechanisms to be in place for data sharing. As of May
2011, 35 states had operational monitoring programs, and
13 additional states had passed enacting legislation.
The
third component, proper medication disposal, is essential
because the public lacks a safe, convenient, and
environmentally responsible way to dispose of medications
that are no longer needed. DEA is drafting rules to
provide easier access to drug disposal. In support of
medication disposal efforts, DEA held National
Prescription Drug Take-Back Events in 2010 and 2011.
During the first two such events, approximately 309 tons
of drugs were collected at over 5,000 sites across the
country.
The
fourth component calls on law enforcement agencies to help
decrease prescription drug diversion and abuse. The
majority of prescribers are responsible, but unscrupulous
persons continue to operate outside of legitimate medical
practice. These persons must be held accountable, and the
plan outlines specific actions the federal government can
take to help law enforcement agencies effectively address
pill mills and doctor shopping.
The
CDC says the two main groups at risk for prescription drug
overdose are the nine million people who report long-term
medical use of opioids, and the roughly 5 million who have
used opioids without a prescription or medical need in the
past month.
Family History of Alcoholism May Affect Teens’ Decision-Making
A
family history of alcoholism may affect teenagers’
decision-making, researchers at Oregon Health and Sciences
University have found. They discovered these adolescents
have a weaker brain response during risky decision-making
compared with teens without such a family history.
The
researchers studied 31 teens ages 13 to 15. Of these, 18
had a family history of alcoholism. All of the teens’
brains were scanned using functional magnetic resonance
imaging, to examine responses during an activity that
mimicked the TV show Wheel of Fortune. The game presented
risky and safe probabilities of winning different sums of
money.
In
the teens with a family history of alcoholism, the
researchers noted that two areas of the brain responded
differently, UPI reports. These brain areas are important
for executive functioning, which guide complex behavior
through planning, decision-making and response control.
This group of teens showed weaker brain responses during
risky decision-making, compared with teens who did not
have a family history of alcoholism.
The
researchers conclude in the journal Alcoholism:
Clinical & Experimental Research, “Atypical
brain activity, in regions implicated in executive
functioning could lead to reduced cognitive control, which
may result in risky choices regarding alcohol use.”
Many States Receive Failing Grades in Lung Association Report on
Anti-Tobacco Efforts
Many
states received failing grades on the latest American Lung
Association report card rating tobacco control efforts.
Forty-three states and the District of Columbia earned an
“F” for funding smoking-prevention programs at
less than half the levels recommended by the Centers for
Disease Control and Prevention (CDC).
Alaska
was the only state that funded tobacco programs at the
CDC’s recommended levels, Bloomberg Businessweek
reports. Overall, states’ collective spending on
anti-smoking programs dropped 11 percent last year, and
only Vermont and Connecticut raised cigarette taxes. Eight
states rejected cigarette tax proposals, while New
Hampshire decreased its cigarette tax 10 cents per pack,
according to the report, the State of Tobacco Control.
“At
a time when our country is trying to get a handle on
health-care spending, this is an enormous expense that
could be avoided by investing in effective
tobacco-prevention and cessation programs and policies,”
said American Lung Association President and Chief
Executive Officer, Charles Connor.
The
report covered four policy areas: cigarette taxes, smoking
bans, tobacco-prevention spending and cessation coverage.
Four states—Delaware, Hawaii, Maine and
Oklahoma—received passing grades in all four areas,
while six states—Alabama, Mississippi, Missouri, South
Carolina, Virginia and West Virginia—failed in all four
categories.
The
federal government made some progress in tobacco control,
by beginning to offer comprehensive smoking cessation
benefits to millions of federal employees and their
families, the report noted. The federal government also
announced it will give states partial reimbursement for
smoking cessation counseling services for Medicaid
enrollees through state toll-free phone quitlines.